Immunomodulatory Role and Clinical Impact of Erythromycin in Critically Septic Patients: a Randomized Clinical Trial
Latest Information Update: 19 Apr 2024
At a glance
- Drugs Erythromycin estolate (Primary) ; Cytokines; Interleukin-10
- Indications Sepsis; Septic shock
- Focus Therapeutic Use
- 18 Apr 2024 Primary endpoint (Change of TNF / IL-10 ratio) has not been met, according to Results published in the Journal of Critical Care.
- 18 Apr 2024 Results published in the Journal of Critical Care.
- 10 May 2023 Status changed from recruiting to completed.